bit.bio (private company)
See something wrong or missing? Let us know
Offices:Cambridge
Business model:B2B
Bit.bio is a British biotech startup founded by Mark Kotter and led by Jonathan Milner, which specializes in the fields of coding and biology as it develops a scalable technology platform capable of producing consistent batches of every human cell.
Investors:
we tracked 17 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 174.97M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to bit.bio
| Name | Criteria | |
|---|---|---|
![]() |
Atai Life Sciences
80%
|
|
![]() |
Semble
80%
|
|
![]() |
Sano Genetics
80%
|
|
![]() |
Skin Analytics
80%
|
|
![]() |
Synapse Medicine
80%
|
|
![]() |
Teton.ai
80%
|
|
![]() |
Valink Therapeutics
80%
|
|
![]() |
Kheiron
80%
|
|
![]() |
Causaly
80%
|
|
![]() |
Kyan Health
80%
|
|





Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain